IP Library Granted Patent US 10,898,520
Granted Patent B2
US 10,898,520 · App. 15/901,374 · Granted Jan 26, 2021

Methods for rejuvinating red blood cells

Inventor: Alan David Gray (North Reading, MA)
Assignee: Biomet Biologics, LLC
A61K35/18A61K47/00A61M1/0209A61M1/0218A61M1/0272A61M1/0281A61M1/3621A61M1/3692A61M1/3693C12N5/0641C12N2501/999
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,898,520
App. No.
15/901,374
Granted
Jan 26, 2021
Kind
B2
Abstract

Methods and a system for transfusing blood to a mammalian subject. The method includes obtaining a volume of donated red blood cells (RBCs), adding an enhancement composition to the RBCs to form a treated blood composition, incubating the treated blood composition to form an incubated blood composition, and administering the incubated blood composition to a patient. The system includes a functionally-closed, sterile Y-type tube set.

Claims (19)

1. A method for processing a blood component comprising the steps of:

adding an enhancement composition to a volume comprising red blood cells (RBCS) to form an RBC composition, wherein the enhancement composition comprises inosine, adenine, pyruvate, sodium phosphate, or a mixture thereof;

incubating the RBC composition at a temperature between 37° C. and 45° C. for a period; and

mixing the RBC composition while the RBC composition is incubating at the temperature.

2. The method of claim 1 , wherein the RBC enhancement composition comprises about 25 g/L to about 30 g/L inosine, about 0.2 g/L to about 2 g/L adenine, about 5 g/L to about 15 g/L pyruvate, and about 17 g/L to about 23 g/L sodium phosphate, or a combination thereof.

3. The method of claim 1 , wherein the RBC enhancement composition comprises about 27 g/L inosine, about 11 g/L pyruvate, about 0.7 g/L adenine, and about 21 g/L sodium phosphate.

4. The method of claim 3 , wherein the sodium phosphate comprises about 6.2 g/L sodium phosphate, monobasic, monohydrate; and about 14.6 g/L sodium phosphate, dibasic, heptahydrate.

5. The method of claim 1 , wherein the incubating is in a dry heat.

6. The method of claim 1 , wherein the incubating is not in a water bath.

7. The method of claim 1 , wherein the mixing includes swirling, shaking, rotating, or agitating the RBC composition.

8. The method of claim 1 , wherein the period is from about 30 minutes to about 90 minutes.

9. The method of claim 1 , wherein the volume comprising red blood cells was stored at a preservation temperature prior to the adding step.

10. The method of claim 1 , wherein the volume comprising red blood cells has been leukocyte reduced.

11. The method according to claim 1 , wherein the treated RBC composition is for autologous transfusion.

12. The method of claim 1 , wherein the incubating is for about 60 minutes at a temperature of about 37° C. and is not in a water bath.

13. The method of claim 1 , further comprising washing the treated RBCS.

14. The method of claim 13 , wherein the adding, incubating and washing steps are performed in a continuous process in a closed system at a point of care.

15. The method of claim 1 , further comprising measuring the partial pressure of oxygen required to obtain 50% hemoglobin saturation (p50) of the treated RBCS.

16. The method of claim 1 , wherein the adding includes passing the composition through a filter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2021
From: BIOMET BIOLOGICS, LLC
To: BIOMET MANUFACTURING, LLC
Reel/Frame 057281/0793 →